Healthcare, delivered intelligently. Everywhere.

A standalone clinic has no moat, and we would not argue otherwise. The defensibility comes from the combination of multi-year enterprise contracts, captive last-mile presence inside large industrial ecosystems, full-stack orchestration across primary care, diagnostics, telemedicine and referrals, and longitudinal exposure-linked data created continuously at scale. Plant access, clinical licences and operating permissions are secured in LMC's name and integrated with client HRMS and ERP systems. These typically involve 6–12 month approval cycles that a challenger has to restart from zero. Switching also means migrating compliance history, creating regulatory risk for the employer. The clinic is what is visible; the data layer is the moat.

Services are employer-funded, which matters because 62% of healthcare spending is out-of-pocket—the problem LMC exists to address. Where LMC sets up a physical clinic, pricing runs on a per-worker-per-month basis depending on the test panel. For service-sector clients, LMC uses the phlebotomist model, with an annual health checkup priced as a one-time charge. Where a worker pays directly for services such as pharmacy, advanced diagnostics or spectacles, LMC's pre-negotiated rates are typically 30–40% below open-market prices, and the transaction is still added to the worker's longitudinal health record.

Standard mandates are two-year contracts with renewal, while anchor accounts are signed for three to five years. Renewal is supported by two structural factors: the statutory checkup obligation recurs every year by law, and LMC holds the site permissions, IT integrations and compliance history. LMC's enterprise base has shown near-zero churn once a deployment is live.

Approximately 20% of sites have a doctor on site, primarily hybrid community service centres and locations where the client mandate specifies a resident physician. Industrial sites typically operate on a nurse-led, telemedicine-first model, with trained nurses and phlebotomists on the ground, physician tele-consultations on demand, defined escalation protocols, and mobile medical vans for camps and screenings. This is a deliberate design choice rather than a resourcing gap. Statutory compliance does not require a resident doctor at every industrial site, and the nurse-led model makes the pricing viable while enabling operations in locations where full-time physicians may not be available. As mandates deepen, doctor-led sites can be added.

There are three primary reasons. First, some workers requiring higher levels of care are routed through government insurance schemes, which may restrict treatment to government or empanelled hospitals. LMC clinically guides these cases, but they do not transact through LMC's referral line. Second, most historical referrals in this population occurred because no primary care layer existed. LMC's MBBS doctors resolve the majority of presenting conditions through medication and structured lifestyle intervention. Third, protocol discipline ensures that only chronic, complex or potentially life-threatening cases are escalated. The ~1% figure reflects referral volume when a functioning primary care layer is in place, rather than suppressed demand.

The model is based on single accountability, not single ownership. The client signs one contract with LMC. Empanelled laboratories, specialists and hospitals operate under LMC's negotiated rate cards, SOPs and quality audits. Every transaction, whether delivered by an LMC nurse or a partner lab, is recorded in the worker's single 1Care OS record. From both the employer's and worker's perspective, there is one vendor, one service-level agreement and one health record. Owning the entire network of hospitals, labs and pharmacies would undermine the unit economics. Aggregating them under one governance and data layer is the model.

No, and deliberately so. At 310,000+ records, the dataset is still below the roughly one-million-record threshold at which cohorts can achieve stronger statistical significance by occupation, age band and geography. At that scale, the Intelligence API could become valuable to insurers, researchers and government. Individual records are never sold. The API is intended to expose only anonymised, aggregated and consented patterns—not individual people.

LMC owns the staffing, infrastructure, licences and clinical governance of every centre. The physical space is typically provided by the employer within its premises. Medical equipment and IT are either LMC capital expenditure or client-funded, depending on the mandate. Clinical operations, SOPs, quality assurance and health records always remain with LMC. Mobile medical vans are owned or long-term leased and operated by LMC, allowing a single van to serve multiple clients across a cluster. The structure is intentionally asset-light, with capital focused on equipment and technology rather than real estate.